Coenzyme Q10 serves to couple mitochondrial oxidative phosphorylation and fatty acid β-oxidation, and attenuates NLRP3 inflammasome activation

Suphannee Chokchaiwong, Yung Ting Kuo, Shih Hsiang Lin, Yi Ching Hsu, Sung Po Hsu, Yu Ting Liu, An Je Chou, Shu Huei Kao

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Multiple acyl-CoA dehydrogenase deficiency (MADD), an autosomal recessive metabolic disorder of fatty acid metabolism, is mostly caused by mutations in the ETFA, ETFB or ETFDH genes that result in dysfunctions in electron transfer flavoprotein (ETF) or electron transfer flavoprotein-ubiquinone dehydrogenase (ETFDH). In β-oxidation, fatty acids are processed to generate acyl-CoA, which is oxidised by flavin adenine dinucleotide and transfers an electron to ETF and, through ETFDH, to mitochondrial respiratory complex III to trigger ATP synthesis. Coenzyme Q10 (CoQ10) is believed to be a potential treatment that produces symptom relief in some MADD patients. CoQ10 acts as a key regulator linking ETFDH and mitochondrial respiratory complex III. Our aim is to investigate the effectiveness of CoQ10 in serving in the ETF/ETFDH system to improve mitochondrial function and to reduce lipotoxicity. In this study, we used lymphoblastoid cells with an ETFDH mutation from MADD patients. ETFDH dysfunction caused insufficient β-oxidation, leading to increasing lipid droplet and lipid peroxide accumulation. In contrast, supplementation with CoQ10 significantly recovered mitochondrial function and concurrently decreased the generation of reactive oxygen species and lipid peroxides, inhibited the accumulation of lipid droplets and the formation of the NOD-like receptor family pyrin domain-containing three (NLRP3) inflammasome, and reduced interleukin-1β release and cell death. These results clarify the causal role of CoQ10 in coupling the electron transport chain with β-oxidation, which may promote the development of CoQ10-directed therapies for MADD patients.

Original languageEnglish
JournalFree Radical Research
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

coenzyme Q10
Electron-Transferring Flavoproteins
Inflammasomes
Oxidative Phosphorylation
Ubiquinone
Fatty Acids
Chemical activation
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
Oxidation
Oxidoreductases
Acyl-CoA Dehydrogenase
Electron Transport Complex III
Lipid Peroxides
Lipids
Acyl Coenzyme A
Mutation

Keywords

  • Coenzyme Q10
  • electron transfer flavoprotein dehydrogenase
  • inflammasome
  • mitochondrial function
  • multiple acyl-CoA dehydrogenase deficiency

ASJC Scopus subject areas

  • Biochemistry

Cite this

Coenzyme Q10 serves to couple mitochondrial oxidative phosphorylation and fatty acid β-oxidation, and attenuates NLRP3 inflammasome activation. / Chokchaiwong, Suphannee; Kuo, Yung Ting; Lin, Shih Hsiang; Hsu, Yi Ching; Hsu, Sung Po; Liu, Yu Ting; Chou, An Je; Kao, Shu Huei.

In: Free Radical Research, 01.01.2018.

Research output: Contribution to journalArticle

@article{4c3f54ddd3104dcaa423d29e309e486e,
title = "Coenzyme Q10 serves to couple mitochondrial oxidative phosphorylation and fatty acid β-oxidation, and attenuates NLRP3 inflammasome activation",
abstract = "Multiple acyl-CoA dehydrogenase deficiency (MADD), an autosomal recessive metabolic disorder of fatty acid metabolism, is mostly caused by mutations in the ETFA, ETFB or ETFDH genes that result in dysfunctions in electron transfer flavoprotein (ETF) or electron transfer flavoprotein-ubiquinone dehydrogenase (ETFDH). In β-oxidation, fatty acids are processed to generate acyl-CoA, which is oxidised by flavin adenine dinucleotide and transfers an electron to ETF and, through ETFDH, to mitochondrial respiratory complex III to trigger ATP synthesis. Coenzyme Q10 (CoQ10) is believed to be a potential treatment that produces symptom relief in some MADD patients. CoQ10 acts as a key regulator linking ETFDH and mitochondrial respiratory complex III. Our aim is to investigate the effectiveness of CoQ10 in serving in the ETF/ETFDH system to improve mitochondrial function and to reduce lipotoxicity. In this study, we used lymphoblastoid cells with an ETFDH mutation from MADD patients. ETFDH dysfunction caused insufficient β-oxidation, leading to increasing lipid droplet and lipid peroxide accumulation. In contrast, supplementation with CoQ10 significantly recovered mitochondrial function and concurrently decreased the generation of reactive oxygen species and lipid peroxides, inhibited the accumulation of lipid droplets and the formation of the NOD-like receptor family pyrin domain-containing three (NLRP3) inflammasome, and reduced interleukin-1β release and cell death. These results clarify the causal role of CoQ10 in coupling the electron transport chain with β-oxidation, which may promote the development of CoQ10-directed therapies for MADD patients.",
keywords = "Coenzyme Q10, electron transfer flavoprotein dehydrogenase, inflammasome, mitochondrial function, multiple acyl-CoA dehydrogenase deficiency",
author = "Suphannee Chokchaiwong and Kuo, {Yung Ting} and Lin, {Shih Hsiang} and Hsu, {Yi Ching} and Hsu, {Sung Po} and Liu, {Yu Ting} and Chou, {An Je} and Kao, {Shu Huei}",
year = "2018",
month = "1",
day = "1",
doi = "10.1080/10715762.2018.1500695",
language = "English",
journal = "Free Radical Research",
issn = "1071-5762",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Coenzyme Q10 serves to couple mitochondrial oxidative phosphorylation and fatty acid β-oxidation, and attenuates NLRP3 inflammasome activation

AU - Chokchaiwong, Suphannee

AU - Kuo, Yung Ting

AU - Lin, Shih Hsiang

AU - Hsu, Yi Ching

AU - Hsu, Sung Po

AU - Liu, Yu Ting

AU - Chou, An Je

AU - Kao, Shu Huei

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Multiple acyl-CoA dehydrogenase deficiency (MADD), an autosomal recessive metabolic disorder of fatty acid metabolism, is mostly caused by mutations in the ETFA, ETFB or ETFDH genes that result in dysfunctions in electron transfer flavoprotein (ETF) or electron transfer flavoprotein-ubiquinone dehydrogenase (ETFDH). In β-oxidation, fatty acids are processed to generate acyl-CoA, which is oxidised by flavin adenine dinucleotide and transfers an electron to ETF and, through ETFDH, to mitochondrial respiratory complex III to trigger ATP synthesis. Coenzyme Q10 (CoQ10) is believed to be a potential treatment that produces symptom relief in some MADD patients. CoQ10 acts as a key regulator linking ETFDH and mitochondrial respiratory complex III. Our aim is to investigate the effectiveness of CoQ10 in serving in the ETF/ETFDH system to improve mitochondrial function and to reduce lipotoxicity. In this study, we used lymphoblastoid cells with an ETFDH mutation from MADD patients. ETFDH dysfunction caused insufficient β-oxidation, leading to increasing lipid droplet and lipid peroxide accumulation. In contrast, supplementation with CoQ10 significantly recovered mitochondrial function and concurrently decreased the generation of reactive oxygen species and lipid peroxides, inhibited the accumulation of lipid droplets and the formation of the NOD-like receptor family pyrin domain-containing three (NLRP3) inflammasome, and reduced interleukin-1β release and cell death. These results clarify the causal role of CoQ10 in coupling the electron transport chain with β-oxidation, which may promote the development of CoQ10-directed therapies for MADD patients.

AB - Multiple acyl-CoA dehydrogenase deficiency (MADD), an autosomal recessive metabolic disorder of fatty acid metabolism, is mostly caused by mutations in the ETFA, ETFB or ETFDH genes that result in dysfunctions in electron transfer flavoprotein (ETF) or electron transfer flavoprotein-ubiquinone dehydrogenase (ETFDH). In β-oxidation, fatty acids are processed to generate acyl-CoA, which is oxidised by flavin adenine dinucleotide and transfers an electron to ETF and, through ETFDH, to mitochondrial respiratory complex III to trigger ATP synthesis. Coenzyme Q10 (CoQ10) is believed to be a potential treatment that produces symptom relief in some MADD patients. CoQ10 acts as a key regulator linking ETFDH and mitochondrial respiratory complex III. Our aim is to investigate the effectiveness of CoQ10 in serving in the ETF/ETFDH system to improve mitochondrial function and to reduce lipotoxicity. In this study, we used lymphoblastoid cells with an ETFDH mutation from MADD patients. ETFDH dysfunction caused insufficient β-oxidation, leading to increasing lipid droplet and lipid peroxide accumulation. In contrast, supplementation with CoQ10 significantly recovered mitochondrial function and concurrently decreased the generation of reactive oxygen species and lipid peroxides, inhibited the accumulation of lipid droplets and the formation of the NOD-like receptor family pyrin domain-containing three (NLRP3) inflammasome, and reduced interleukin-1β release and cell death. These results clarify the causal role of CoQ10 in coupling the electron transport chain with β-oxidation, which may promote the development of CoQ10-directed therapies for MADD patients.

KW - Coenzyme Q10

KW - electron transfer flavoprotein dehydrogenase

KW - inflammasome

KW - mitochondrial function

KW - multiple acyl-CoA dehydrogenase deficiency

UR - http://www.scopus.com/inward/record.url?scp=85053431080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053431080&partnerID=8YFLogxK

U2 - 10.1080/10715762.2018.1500695

DO - 10.1080/10715762.2018.1500695

M3 - Article

JO - Free Radical Research

JF - Free Radical Research

SN - 1071-5762

ER -